Principal Investigator
Wendy Lee
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210199
Clinical Trial Summary
The effect of Upneeq (oxymetazoline hydrochloride 0.1%) on palpebral fissure height, eye redness, and patient-reported eye appearance
Phase
Phase IV
Funding Agency/Sponsor
Intramural
Disease
Other